Literature DB >> 34737675

Influenza vaccine during the 2019-2020 season and COVID-19 risk: A case-control study in Québec.

Jacques Pépin1, Philippe De Wals2, Annie-Claude Labbé3,4, Alex Carignan1, Marie-Elise Parent5, Jennifer Yu5, Louis Valiquette1, Marie-Claude Rousseau5.   

Abstract

BACKGROUND: We carried out a case-control study that examined whether receipt of the inactivated influenza vaccine during the 2019-2020 season impacted on the risk of coronavirus disease 2019 (COVID-19), as there was a concern that the vaccine could be detrimental through viral interference.
METHODS: A total of 920 cases with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (diagnosed between March and October 2020) and 2,123 uninfected controls were recruited from those who were born in Québec between 1956 and 1976 and who had received diagnostic services at two hospitals (Montréal and Sherbrooke, Québec). After obtaining consent, a questionnaire was administered by phone. Data were analyzed by logistic regression.
RESULTS: Among healthcare workers, inactivated influenza vaccine received during the previous influenza season was not associated with increased COVID-19 risk (AOR: 0.99, 95% CI: 0.69-1.41). Among participants who were not healthcare workers, influenza vaccination was associated with lower odds of COVID-19 (AOR: 0.73, 95% CI 0.56-0.96).
CONCLUSION: We found no evidence that seasonal influenza vaccine increased the risk of developing COVID-19.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; influenza vaccine; seasonal influenza

Year:  2021        PMID: 34737675      PMCID: PMC8525604          DOI: 10.14745/ccdr.v47i10a05

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  13 in total

1.  Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.

Authors:  David Kim; James Quinn; Benjamin Pinsky; Nigam H Shah; Ian Brown
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

2.  Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; Naveed Z Janjua; Nicole Boulianne; Travis S Hottes; Laura C Rosella; James A Dickinson; Rodica Gilca; Pam Sethi; Najwa Ouhoummane; Donald J Willison; Isabelle Rouleau; Martin Petric; Kevin Fonseca; Steven J Drews; Anuradha Rebbapragada; Hugues Charest; Marie-Eve Hamelin; Guy Boivin; Jennifer L Gardy; Yan Li; Trijntje L Kwindt; David M Patrick; Robert C Brunham
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

3.  The association of previous influenza vaccination and coronavirus disease-2019.

Authors:  Ilan Green; Shai Ashkenazi; Eugene Merzon; Shlomo Vinker; Avivit Golan-Cohen
Journal:  Hum Vaccin Immunother       Date:  2020-12-30       Impact factor: 3.452

4.  Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design.

Authors:  Julia Stowe; Elise Tessier; H Zhao; Rebecca Guy; Berit Muller-Pebody; Maria Zambon; Nick Andrews; Mary Ramsay; Jamie Lopez Bernal
Journal:  Int J Epidemiol       Date:  2021-05-03       Impact factor: 7.196

5.  Validation of self-reported influenza vaccination in the current and prior season.

Authors:  Jennifer P King; Huong Q McLean; Edward A Belongia
Journal:  Influenza Other Respir Viruses       Date:  2018-08-14       Impact factor: 4.380

6.  Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season.

Authors:  Greg G Wolff
Journal:  Vaccine       Date:  2019-10-10       Impact factor: 3.641

7.  Influenza vaccination and the risk of COVID-19 infection and severe illness in older adults in the United States.

Authors:  Kelly Huang; Shu-Wen Lin; Wang-Huei Sheng; Chi-Chuan Wang
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

8.  The Association between Influenza Vaccination and the Risk of SARS-CoV-2 Infection, Severe Illness, and Death: A Systematic Review of the Literature.

Authors:  Marco Del Riccio; Chiara Lorini; Guglielmo Bonaccorsi; John Paget; Saverio Caini
Journal:  Int J Environ Res Public Health       Date:  2020-10-27       Impact factor: 3.390

9.  Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019-2020 season.

Authors:  Jennifer P King; Huong Q McLean; Edward A Belongia
Journal:  Influenza Other Respir Viruses       Date:  2021-06-25       Impact factor: 5.606

10.  Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.

Authors:  Danuta M Skowronski; Macy Zou; Suzana Sabaiduc; Michelle Murti; Romy Olsha; James A Dickinson; Jonathan B Gubbay; Matthew A Croxen; Hugues Charest; Agatha Jassem; Mel Krajden; Nathalie Bastien; Yan Li; Gaston De Serres
Journal:  Euro Surveill       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.